期刊文献+

胞外Y-盒结合蛋白1通过Notch3受体促进肝癌细胞HepG2的增殖与转移 被引量:4

Extracellular Y-box binding protein-1 promotes proliferation and metastasis of HepG2 cells through Notch3 receptor
原文传递
导出
摘要 目的 阐明应激状态下肝癌细胞HepG2是否主动分泌Y-盒结合蛋白1(YB-1),并初步探讨胞外YB-1的病理意义与作用机制. 方法 浓度梯度的脂多糖(LPS)、阿霉素刺激处理HepG2,离心收集培养上清液,采用已建立的化学发光免疫分析法(CLIA)实时定量检测上清液中YB-1水平;免疫共沉淀技术检测胞外YB-1是否特异结合Notch3受体,Western blot分析Notch-跨腹受体表达;浓度梯度的重组YB-1与HepG2共培养,四甲基偶氮唑盐法与细胞迁移实验检测HepG2细胞的增殖与侵袭转移.多组间数据比较采用单因素方差分析. 结果 CLIA检测结果显示培养液上清液中胞外YB-1水平显著高于对照组(F=10.54,P<0.001),分泌表达量在刺激培养(LPS:8 ng/ml和阿霉素:10 ng/ml)4 h后达高峰;免疫共沉淀与Westem blot结果证实胞外YB-1特异结合并上调表达Notch3;四甲基偶氮唑盐法与细胞迁移实验表明胞外YB-1显著促进HepG2细胞的增殖与侵袭转移(F=9.405,P<0.001).结论 化疗药物等应激状态下肿瘤细胞HepG2可经非经典途径主动分泌YB-1,胞外YB-1特异结合并上调表达Notch3受体,进而促进HepG2细胞的增殖与侵袭转移.为阐明肝细胞肝癌发病机制及进一步探讨胞外YB-1与恶性肿瘤的生物学关系奠定了基础. Objective To clarifywhether HepG2 cells actively secrete Y-box binding protein-1 (YB-1) under stress conditions,and to investigate the pathological significance and mechanism of action of extracellular YB-1.Methods HepG2 cells were stimulated and treated by gradient concentrations of lipopolysaccharide (LPS) and adtiamycin,the supematant of the culture solution was collected by centrifugation,and the established chemiluminescence immunoassay (CLIA) was used for real-time quantitative determination of YB-1 level in the supernatant.The co-immunoprecipitation assay was used to detect whether extracellular YB-1 specifically bound to Notch3 receptor,and Western blot was used to measure the expression of Notch-NICD.The gradient concentrations of recombinant YB-1 were co-cultured with HepG2 cells,and MTT and migration assays were used to analyze the proliferation and invasion/metastasis of HepG2 cells.One-way analysis of variance was used for comparison of data between multiple groups.Results The results of CLIA confirmed that the level of extracellular YB-1 in the supematant was significantly higher than that in the control group (F =10.54,P 〈 0.001),and the secretory expression of YB-1 reached its peak after 4 hours of stimulation (LPS:8 ng/ml;adriamycin:10 ng/ml).The results of co-immunoprecipitation assay and Western blot showed that extracellular YB-1 specifically bound to Notch3 receptor and upregulated the expression of the Notch3 receptor.MTT and migration assays showed that extracellular YB-1 significantly promoted the proliferation and invasion/metastasis of HepG2 cells (F =9.405,P 〈 0.001).Conclusion Under the stress conditions induced by chemotherapeutics,HepG2 cells can actively secrete YB-1 via non-classical pathways.Extracellular YB-1 can specifically bind to Notch3 receptor and further up-regulate its expression,and then promote the proliferation and invasion/metastasis of HepG2 cells.This study lays a foundation for further clarifying the pathogenesis of hepatocellular carcinoma and investigating the biological relationship between extracellular YB-1 and malignant tumors.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2016年第3期202-206,共5页 Chinese Journal of Hepatology
基金 国家临床重点专科建设项目经费资助[财社(2010)305号] 重庆市渝中区科技计划项目(20140120) 重庆市科委科技项目(cstc2015jcyjAl0079)
关键词 肝细胞 细胞增殖 胞外Y盒结合蛋白1 Notch3受体 Carcinoma, hepatocellular Cell proliferation Extracellular Y-box binding protein 1 Notch3 receptor
  • 相关文献

参考文献9

  • 1Lasham A,Print CG,Woolley AG,et al.YB-1:oncoprotein,prognostic marker and therapeutic target?[J].Biochem J,2013,449(1):11-23.DOI:10.1042/BJ20121323.
  • 2Ranganathan P,Wearer KL,Capobianco AJ.Capobianco.Notch signalling in solid tumours:a little bit of everything but not all the time[J].Nat Rev Cancer,2011,11(5):338-351.DOI:10.1038/ nrc3035.
  • 3Pu L,Jing S,Bianqin G,et al.Development of a chemiluminescence immunoassay for serum YB-1 and its clinical application as a potential diagnostic marker for hepatocellular carcinoma[J].Hepat Mon,2013,13(7):e8918.DOI:10.5812/hepatmon.8918.
  • 4Zhang Q,Lu C,Fang T,et al.Notch3 functions as a regulator of cell self-renewal by interacting with the beta-catenin pathway in hepatocellular carcinoma[J].Oncotarget,2015,6(6):3669-3679.DOI:10.18632/oncotarget.2898.
  • 5李朴,史静,成凤,梁勤东,匡文斌,王秦,董晋豫,涂植光.Y盒结合蛋白1单克隆抗体的研制、表位测定及其免疫学应用[J].中国生物工程杂志,2012,32(6):13-19. 被引量:5
  • 6李朴,孔飞飞,余雪梅,成凤,涂植光.人YB-1蛋白的高效原核表达、纯化及其多抗的制备[J].第三军医大学学报,2010,32(14):1579-1581. 被引量:10
  • 7Frye BC,Halfter S,Djudjaj S,et al.Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen[J].EMBO Rep,2009,10(7):783-789.DOI:10.1038/ embor.2009.81.
  • 8Rauen T,Raffetseder U,Frye BC,et al.YB-1 acts as a ligand for Notch-3 receptors and modulates receptor activation[J].J Biol Chem,2009.284(39):26928-26940.DOI:10.1074/jbc.M109.046599.
  • 9Gramantieri L,Giovannini C,Lanzi A,et al.Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma[J].Liver Int,2007,27(7):997-1007.DOI:10.1111/j.1478-3231.2007.01544.x.

二级参考文献22

  • 1Kohno K, Izumi H, Uchiumi T, et al. The pleiotropic flmctions of the Y-box-binding protein, YB-1 [J]. Bioessays, 2003, 25(7): 691 -698.
  • 2Kuwano M, Oda Y, Izumi H, et al. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance[ J]. Mol Cancer Ther, 2004, 3(11) : 1485 -1492.
  • 3Basaki Y, Hosoi F, Oda Y, et al. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells[ J]. Oncogene, 2007, 26 (19) : 2736 - 2746.
  • 4Graslund S, Nordlund P, Weigelt J, et al. Protein production and purification[J]. Nat Methods, 2008, 5(2): 135 -146.
  • 5Bader A G, Vogt P K. Phosphorylation by Akt disables the anti-oncogenic activity of YB-1 [J]. Oncogene, 2008, 27(8) : 1179 - 1182.
  • 6McCubrey J A, Steelman L S, Abrams S L, et al. Roles of the RAF/ MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformatin and drug resistance[ J]. Adv Enzyme Regul, 2006, 46 : 249 - 279.
  • 7Scherf U, Ross D T, Waltham M, et al. A gene expression database for the molecular pharmacology of cancer [ J ]. Nat Genet, 2000, 24 (3) : 236 -244.
  • 8Kohno K, Izumi H, Uchiumi T, et al. The pleiotropic functions of the Y-box-binding protein, YB-1. BioEssays, 2003, 25 (7) : 691-698.
  • 9Bader A G, Vogt P K. Phosphorylation by Akt disables the antioncogenic activity of YB-1. Oncogene, 2008, 27 (8) : 1179- 1182.
  • 10Bergmann S, Royer-Pokora B, Fietze E, et al. YB-I provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res, 2005, 65(10): 4078-4087.

共引文献12

同被引文献32

  • 1Cao H, H u Y, Wang P, et al. Down-regulation of Notch recep- tor signaling pathway induces easpase-dependent and caspase- independent apoptosis in lung squamous cell carcinoma cells [J]. APMIS,2012,120(6) :441-450.
  • 2Ito T, Udaka N, Yazawa T, et al. Basic helix-loop-helix tran- scription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium [ J ]. Development, 2000,127 (18) 3913-3921.
  • 3Jin M M,Ye Y Z,Qian Z D,et al. Notch signaling molecules as prognostic biomarkers for non-small cell lung cancer[J]. Oncol Lett,2015,10(5) :3252-3260.
  • 4Finkbeiner M R,Astanehe A,To K,et al. Profiling YB-1 target genes uncovers a new mechanism for MET rec-eptor regulation in normal and malignant hu- man mammary eells[J]. Oneogene, 2009,28( 11), 1421-1431.
  • 5Moran S T, Cariappa A, Liu H, et al. Synergism between NF- kappa B1/pS0 and Notch2 during the development of marginal zone B lymphocytes[J]. J Immunol,2007,179(1) : 195-200.
  • 6Chen Y, De Marco M A, Graziani I, et al. Oxygen concentration determines the biological effects of NOTCH-1 signaling in ade nocarcinoma of the lung[J]. Cancer Res, 2007,67(17)..7954- 7959.
  • 7Osipo C, Patel P, Rizzo P, et al. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor[J]. Oncogene, 2008,27(37) : 5019-5032.
  • 8Kashihara M, Azuma K, Kawahara A, et al. Nuclear Y-boxbinding protein-1 ,a predictive marker of prognosis,is correla- ted with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer[J]. J Thorac Oncol, 2009,4 (9) : 1066-1074.
  • 9Ha B,Lee E B, Cui J,et al. YB-1 overexpression promotes a TGF-131-induced epithelial-mesenchymal transition via Akt ac- tivation[J]. Biochem Biophys Res Commun, 2015,458 (2) : 347-351.
  • 10Goldsmith M E, Madden M J, Morrow C S, et al. A Y-box con- sensus sequence is required for basal expression of the human multidrug resistance (mdrl) gene[J]. J Biol Chem, 1993,268 (8) : 5856-5860.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部